Ciby Abraham is a Regulatory CMC Director in Global Regulatory Affairs at AstraZeneca.
Prior to his role with AstraZeneca, Ciby worked at the FDA as a review chemist and a quality
assessment lead for 7 years. In addition, Ciby worked 8 years in the industry as a formulator,
analytical method development scientist, and a manufacturing specialist. He was also licensed
by the New York State Board of Pharmacy to release compounded products to the market. Ciby
holds a Ph.D. in chemistry from Johns Hopkins University, Master’s degree in chemistry from
St. John’s University, and a Bachelor’s degree in chemistry from Binghamton University.